BROWSE BY TAGS

• CLS in the News
• Education
• General Health
• Product News
• Technology

H1N1 Shortcomings
April 14, 2010 2:53 PM by Amanda Koehler

The World Health Organization (WHO) recently admitted to shortcomings in its handling of the H1N1 pandemic. According to the Reuters article, this includes "a failure to communicate uncertainties about the new virus as it swept around the globe." Many Read More...

0 comments »     

Company Releases FIT Assay
February 5, 2010 9:15 AM by Amanda Koehler

Polymedco Inc., Cortlandt Manor, NY, recently announced that the FDA has granted 510(k) clearance of the OC-Sensor Diana, a high throughput automated system for the immunoassay fecal occult blood test (FIT) used for detecting gastrointestinal bleeding Read More...

0 comments »     

ViraCor Announces New President, CEO
December 30, 2009 2:09 PM by Amanda Koehler

ViraCor-IBT Laboratories recently named diagnostics industry veteran Mark Roberts, PhD, as the company's president and CEO. Dr. Roberts assumed the position on Nov. 30. Laurence McCarthy, chairman of the ViraCor-IBT Board of Directors, commented: "Mark Read More...

2 comments »     

H1N1 Rates Dropping
November 24, 2009 10:40 AM by Kerri Penno

The 2009 H1N1 influenza virus infection rates may have peaked in late October, but the pandemic flu virus continues to be a potential source of illness in all age groups, including the elderly, according to a new report by Quest Diagnostics Inc. In its Read More...

0 comments »     

Be SMART
September 28, 2009 3:50 PM by Kerri Penno

bioMérieux, an in vitro diagnostics company, heightened its role in the fight against antimicrobial resistance by launching its Solutions to Manage the Antimicrobial Resistance Threat (SMART) Campaign at the 49th Annual Interscience Conference for Antimicrobial Read More...

0 comments »     

FDA Clears Vermillion's OVA1
September 14, 2009 1:00 PM by Kerri Penno

The FDA has cleared Vermillion Inc.'s (Fremont, CA) OVA1 test to help detect ovarian cancer in pelvic masses requiring surgery. OVA1 identifies women who will benefit from referral to a gynecological oncologist for surgery, despite negative results from Read More...

0 comments »